The CNDP1 (CTG)(5) Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration

Considering that the homozygous CNDP1 (CTG)(5) genotype affords protection against diabetic nephropathy (DN) in female patients with type 2 diabetes, this study assessed if this association remains gender-specific when applying clinical inclusion criteria (CIC-DN) or biopsy proof (BP-DN). Additional...

Descripción completa

Detalles Bibliográficos
Autores principales: Albrecht, Thomas, Zhang, Shiqi, Braun, Jana D., Xia, Li, Rodriquez, Angelica, Qiu, Jiedong, Peters, Verena, Schmitt, Claus P., van den Born, Jacob, Bakker, Stephan J. L., Lammert, Alexander, Köppel, Hannes, Schnuelle, Peter, Krämer, Bernhard K., Yard, Benito A., Hauske, Sibylle J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434468/
https://www.ncbi.nlm.nih.gov/pubmed/28553654
http://dx.doi.org/10.1155/2017/9506730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434468/
https://www.ncbi.nlm.nih.gov/pubmed/28553654
http://dx.doi.org/10.1155/2017/9506730

Ejemplares similares